Dyve Biosciences gout treatment shows promise

You are here: Home > Biotech > Current Article

By Staff Report / Friday, March 22nd, 2019 / Comments Off on Dyve Biosciences gout treatment shows promise

A human study of a topical gout pain product from Thousand Oaks-based Dyve Biosciences returned positive results, the company announced March 20. The results of the double-blind proof-of-concept pilot study were presented at a workshop at the European Crystal Network in Paris March 14-15. Dyve products aim to deliver known molecules like sodium bicarbonate –…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.